Hematopoietic Stem Cell Transplant for Hematological Malignancies: Experience from a Tertiary Care Center in Northern India and Review of Indian Data

Hematopoietic stem cell transplantation (HSCT) is the preferred treatment for high-risk and relapsed/refractory hematological malignancies. Moreover, with the improved supportive care and increasing acceptance of haploidentical transplantations as an alternative treatment modality, more patients are...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Sanjeev Kumar, Choudhary, Dharma, Doval, Divya, Khandelwal, Vipin, Setia, Rasika, Dadu, Tina, Handoo, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273315/
https://www.ncbi.nlm.nih.gov/pubmed/35833052
http://dx.doi.org/10.1055/s-0041-1731599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273315/
https://www.ncbi.nlm.nih.gov/pubmed/35833052
http://dx.doi.org/10.1055/s-0041-1731599

Ejemplares similares